Suggestions
Petr Sramek
Managing Partner at Longevitytech.fund and serial entrepreneur
Petr Sramek is a prominent figure in the longevity and health technology sector, currently serving as the Chief Executive Officer of HealthyLongevity.clinic since March 2021.1 His professional focus is on extending healthy and active lifespans through various technological and entrepreneurial endeavors.
Professional Experience
Sramek holds several key positions in the longevity field:
- Managing Partner at Longevitytech.fund since December 2019, where he invests globally in technologies aimed at extending healthy lifespans, focusing on pre-seed and seed startups.1
- Founder and Executive Chairman of HealthyLongevity.cafe since December 2020, which curates personalized health and wellness strategies.1
- Board Member for companies like Celeris Therapeutics and Animal Biosciences Inc., both involved in longevity-related research and interventions.1
Entrepreneurial Ventures
Sramek has a history of founding and leading various companies:
- Co-founder of LongevityForum.eu, which aims to improve society by prolonging healthy and active human life.1
- CEO of Whytics, an AI company focusing on modeling complex systems and developing a Structural Causal Models Inference Machine platform.1
- Founder of AI Startup Incubator from June 2017 to January 2020.1
Education and Expertise
Sramek holds an MBA from Manchester University.1 His expertise spans artificial intelligence, longevity technologies, and business strategy. He has served as an Entrepreneur In Residence at Singularity University and as a mentor for the Founder Institute.1
Recent Achievements
In November 2023, Sramek reported that his epigenetic age (TruAge) had decreased by 10 years over the previous 20 months, totaling a reduction of 16 years and 28% of his chronological age.2 This personal achievement aligns with his professional focus on longevity and health span extension.
Petr Sramek is actively involved in promoting longevity research and technologies, participating in and organizing events such as the Aging Research and Drug Discovery (ARDD) conference3 and contributing to publications like Forbes Czechia on topics related to living well and long.4
Highlights
Deloitte - Living a 140-year long and healthy life
“we predict that breakthroughs in our understanding of aging and well-being will unlock the potential to radically improve existing approaches to care.“
“This longevity ecosystem represents a growing set of players who are shifting away from the traditional disease-focused paradigm, instead addressing the root causes of aging and focusing on keeping patients well. Companies that develop a long-term longevity strategy will be in the best position to influence how this new paradigm evolves. Whether they pursue M&A to gain key knowhow, partner with startups and academic institutions, or leverage their own core competencies, these companies will be better able to compete in a future where humans live longer, healthier lives than ever before.”
(cze) Ekonom opět hodnotí stav v oblasti longevity a ptá se například David Kasper, Alexandra Kala a David Semerad https://lnkd.in/ezDhKF5g HealthyLongevity.clinic CZ HealthyLongevity.cafe LongevityTech.fund
